A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established
NCT06614179 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2024-09-26
Summary
Abdominal noncontrast scan and contrast-enhanced CT were used to establish a screening and diagnostic model for abdominal tumors
Conditions
- Abdominal Neoplasm
Sponsors & Collaborators
-
Xiangdong Cheng
lead OTHER
Principal Investigators
-
Xiangdong Cheng · Zhejiang Cancer Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-01
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- China
Study Locations
More Related Trials
-
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
NCT07181954 ·Status: COMPLETED
-
Radiomics of Hepatocellular Carcinoma
NCT02757846 ·Status: UNKNOWN
-
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
NCT06648317 ·Status: RECRUITING
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis
NCT05778929 ·Status: UNKNOWN
-
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
NCT06126159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors
NCT00269373 ·Status: COMPLETED
-
PET-CT in Diagnosis of Pancreatic Cystic Neoplasms
NCT01317836 ·Status: COMPLETED
-
68Ga-N188 PET/CT Imaging in Malignancy
NCT05593107 ·Status: RECRUITING ·Phase: NA
-
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
NCT06148220 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
NCT05430841 ·Status: COMPLETED ·Phase: NA
-
Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
NCT02245217 ·Status: COMPLETED ·Phase: NA
-
Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer
NCT03015298 ·Status: UNKNOWN
-
A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma
NCT06277206 ·Status: COMPLETED
-
The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
NCT06597526 ·Status: RECRUITING
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer Index
NCT05063019 ·Status: UNKNOWN ·Phase: NA
-
Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data
NCT06533709 ·Status: RECRUITING
-
Role of 18F-FDG PET/CT in Gastric Cancer
NCT05687552 ·Status: UNKNOWN
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors
NCT03568019 ·Status: ACTIVE_NOT_RECRUITING
-
FAPI PET/CT in Various FAP-Related Disease Patients
NCT06688071 ·Status: RECRUITING
-
CLDN18.2 Targeting PET Imaging in Patients With Gastrointestinal Tumors
NCT04883970 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
NCT05626127 ·Status: UNKNOWN
-
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
NCT06601010 ·Status: RECRUITING